These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 24785569)

  • 1. Lentiviral delivery of PPARγ shRNA alters the balance of osteogenesis and adipogenesis, improving bone microarchitecture.
    James AW; Shen J; Khadarian K; Pang S; Chung G; Goyal R; Asatrian G; Velasco O; Kim J; Zhang X; Ting K; Soo C
    Tissue Eng Part A; 2014 Oct; 20(19-20):2699-710. PubMed ID: 24785569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Influence of Tetracycline Inducible Targeting Rat PPARγ Gene Silencing on the Osteogenic and Adipogenic Differentiation of Bone Marrow Stromal Cells.
    Feng X; Liu X; Cai X; Lin T; Xu W; Yang C; Liu Y; Yang S; Fu D
    Curr Pharm Des; 2016; 22(41):6330-6338. PubMed ID: 27396594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S-nitrosoglutathione reductase-dependent PPARγ denitrosylation participates in MSC-derived adipogenesis and osteogenesis.
    Cao Y; Gomes SA; Rangel EB; Paulino EC; Fonseca TL; Li J; Teixeira MB; Gouveia CH; Bianco AC; Kapiloff MS; Balkan W; Hare JM
    J Clin Invest; 2015 Apr; 125(4):1679-91. PubMed ID: 25798618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoblast-targeted suppression of PPARγ increases osteogenesis through activation of mTOR signaling.
    Sun H; Kim JK; Mortensen R; Mutyaba LP; Hankenson KD; Krebsbach PH
    Stem Cells; 2013 Oct; 31(10):2183-92. PubMed ID: 23766271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPARγ suppression inhibits adipogenesis but does not promote osteogenesis of human mesenchymal stem cells.
    Yu WH; Li FG; Chen XY; Li JT; Wu YH; Huang LH; Wang Z; Li P; Wang T; Lahn BT; Xiang AP
    Int J Biochem Cell Biol; 2012 Feb; 44(2):377-84. PubMed ID: 22120652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structurally-diverse, PPARγ-activating environmental toxicants induce adipogenesis and suppress osteogenesis in bone marrow mesenchymal stromal cells.
    Watt J; Schlezinger JJ
    Toxicology; 2015 May; 331():66-77. PubMed ID: 25777084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of targeted PPARγ disruption on bone remodeling.
    Cao J; Ou G; Yang N; Ding K; Kream BE; Hamrick MW; Isales CM; Shi XM
    Mol Cell Endocrinol; 2015 Jul; 410():27-34. PubMed ID: 25666993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The transcription factor NKX1-2 promotes adipogenesis and may contribute to a balance between adipocyte and osteoblast differentiation.
    Chen N; Schill RL; O'Donnell M; Xu K; Bagchi DP; MacDougald OA; Koenig RJ; Xu B
    J Biol Chem; 2019 Nov; 294(48):18408-18420. PubMed ID: 31615896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discoidin Receptor 2 Controls Bone Formation and Marrow Adipogenesis.
    Ge C; Wang Z; Zhao G; Li B; Liao J; Sun H; Franceschi RT
    J Bone Miner Res; 2016 Dec; 31(12):2193-2203. PubMed ID: 27341689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipogenic RNAs are transferred in osteoblasts via bone marrow adipocytes-derived extracellular vesicles (EVs).
    Martin PJ; Haren N; Ghali O; Clabaut A; Chauveau C; Hardouin P; Broux O
    BMC Cell Biol; 2015 Mar; 16():10. PubMed ID: 25887582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloid Elf-1-like factor stimulates adipogenic differentiation through the induction of peroxisome proliferator-activated receptor γ expression in bone marrow.
    Baek K; Cho JY; Hwang HR; Kwon A; Lee HL; Park HJ; Qadir AS; Ryoo HM; Woo KM; Baek JH
    J Cell Physiol; 2012 Nov; 227(11):3603-12. PubMed ID: 22307523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PPARgamma-selective ligand BRL-49653 differentially regulates the fate choices of rat calvaria versus rat bone marrow stromal cell populations.
    Hasegawa T; Oizumi K; Yoshiko Y; Tanne K; Maeda N; Aubin JE
    BMC Dev Biol; 2008 Jul; 8():71. PubMed ID: 18625072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface-specific effects of a PPARgamma agonist, darglitazone, on bone in mice.
    Li M; Pan LC; Simmons HA; Li Y; Healy DR; Robinson BS; Ke HZ; Brown TA
    Bone; 2006 Oct; 39(4):796-806. PubMed ID: 16759917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cultured Human Periosteum-Derived Cells Can Differentiate into Osteoblasts in a Perioxisome Proliferator-Activated Receptor Gamma-Mediated Fashion via Bone Morphogenetic Protein signaling.
    Chung JE; Park JH; Yun JW; Kang YH; Park BW; Hwang SC; Cho YC; Sung IY; Woo DK; Byun JH
    Int J Med Sci; 2016; 13(11):806-818. PubMed ID: 27877072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced femoral bone mass in both diet-induced and genetic hyperlipidemia mice.
    Chen X; Wang C; Zhang K; Xie Y; Ji X; Huang H; Yu X
    Bone; 2016 Dec; 93():104-112. PubMed ID: 27669658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPARγ silencing enhances osteogenic differentiation of human adipose-derived mesenchymal stem cells.
    Lee MJ; Chen HT; Ho ML; Chen CH; Chuang SC; Huang SC; Fu YC; Wang GJ; Kang L; Chang JK
    J Cell Mol Med; 2013 Sep; 17(9):1188-93. PubMed ID: 23937351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oleuropein enhances osteoblastogenesis and inhibits adipogenesis: the effect on differentiation in stem cells derived from bone marrow.
    Santiago-Mora R; Casado-Díaz A; De Castro MD; Quesada-Gómez JM
    Osteoporos Int; 2011 Feb; 22(2):675-84. PubMed ID: 20495905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of peroxisome proliferator-activated receptor-γ in steroid-induced adipogenic differentiation of the bone marrow mesenchymal stem cells of rabbit using small interference RNA.
    Wang Y; Li J; Liu M; Zhao G; Hao L; Li Y
    Chin Med J (Engl); 2014; 127(1):130-6. PubMed ID: 24384438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPAR agonists stimulate adipogenesis at the expense of osteoblast differentiation while inhibiting osteoclast formation and activity.
    Patel JJ; Butters OR; Arnett TR
    Cell Biochem Funct; 2014 Jun; 32(4):368-77. PubMed ID: 24615887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome Proliferator-Activated Receptor-γ Knockdown Impairs Bone Morphogenetic Protein-2-Induced Critical-Size Bone Defect Repair.
    Wang C; Tanjaya J; Shen J; Lee S; Bisht B; Pan HC; Pang S; Zhang Y; Berthiaume EA; Chen E; Da Lio AL; Zhang X; Ting K; Guo S; Soo C
    Am J Pathol; 2019 Mar; 189(3):648-664. PubMed ID: 30593824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.